Tradestie Institutional Equity Comparison Engine
DARE vs MTNB โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MTNB Overall Edge
MTNB Captures Institutional Edge (2โ1 Pillars ยท 4โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Matinas BioPharma Holdings, Inc. (MTNB) driven by superior Growth & Margin, Momentum & Technical while DARE counters with relative strength in Valuation. Fundamentally, DARE trades at 1.3x Forward P/E with -746.1% operating margin (+2005.6% YoY revenue) versus MTNB at N/M Forward P/E and 0.0% operating margin (-100.0% YoY). In options structure, DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MTNB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DARE
DARE 1.3x vs MTNB N/M Fwd P/E
Growth & Margin Winner
MTNB
Op Margin -746.1% vs 0.0% ยท YoY +2005.6% vs -100.0%
Momentum & Technical Winner
MTNB
1Y -74.6% vs -31.4% ยท 52W Pos 1% vs 22%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DARE
NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.45
+0.44% 1D
Market Cap
$8.8M
1M Return
-34.3%
1Y Return
-74.61%
Forward P/E
1.3x
Unified AI Score
43.1 / 100
HOLD
Tech 35.0
Fund 46.0
Flow 50.0
Mom 55.0
MTNB
NYSE American
Matinas BioPharma Holdings, Inc.
Pharmaceutical Preparations
$0.81
-10.98% 1D
Market Cap
$979,904
1M Return
-46.7%
1Y Return
-31.35%
Forward P/E
N/M
Unified AI Score
54.6 / 100
HOLD
Tech 53.0
Fund 58.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
DARE -74.61%
MTNB -31.35%
Spread: +43.26 pp (MTNB Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | DARE Revenue | MTNB Revenue | DARE Op. Margin | MTNB Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -12230.9% | MTNB |
| FY2019 | N/A | $0M | N/A | -21067.4% | MTNB |
| FY2020 | N/A | $0M | N/A | -15288.4% | MTNB |
| FY2021 | N/A | $0M | N/A | -74954.5% | MTNB |
| FY2022 | $10M | $0M | -313.9% | -771.3% | DARE |
| FY2023 | $0M | $0M | -1101.9% | -2168.4% | DARE |
| FY2024 | $0M | N/A | -239692.2% | N/A | DARE |
| FY2025 | $0M | N/A | -1315.5% | N/A | DARE |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DARE | MTNB | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $8.8M | $979,904 | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | 1.3x | N/M | Lower Multiple | DARE |
| Forward P/E Ratio Valuation | 1.3x | N/M | Lower Multiple | DARE |
| Revenue Growth (YoY) Growth | +2005.6% | -100.0% | Higher Growth | DARE |
| Operating Margin (TTM) Profitability | -746.1% | 0.0% | Higher Margin | MTNB |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -407.1% | -147.5% | Higher ROE | MTNB |
| 52-Week Range Position Momentum | 1% ($0โ$4) | 22% ($0โ$3) | Stronger Trend | MTNB |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 112% Vol | -7.20ฮฒ ยท 147% Vol | Lower Realized Risk | DARE |
| Unified Institutional Score Composite Signal | 43.1 / 100 (HOLD) | 54.6 / 100 (HOLD) | Higher Composite | MTNB |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full DARE vs MTNB Buy Guide
DARE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MTNB
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither DARE nor MTNB registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.